EQR vs VIR · P/E 26, $26.37B cap vs rev $238.9M
Equity Residential (EQR) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Equity Residential (EQR) is a reit - residential company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
EQR does not have a complete income-statement cache yet.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
EQR currently screens at market cap $26.37B and trailing P/E 25.7. VIR currently screens at market cap $1.45B.
Not investment advice. Open the EQR and VIR stock pages for the full models.
Not investment advice.